Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

1 results

  • Facial edema as an adverse drug reaction to olanzapine in a patient with cancer receiving palliative care

  • Miguel Julião, Maria Ana Sobral, Tiago Ferreira, Patrícia Calaveiras, Elisabeth Costa, Ana Sara Daniel, Mafalda Lemos-Caldas, Eduardo Bruera
  • Journal:
    Palliative & Supportive Care / Volume 20 / Issue 5 / October 2022
    Published online by Cambridge University Press:
    03 March 2022, pp. 752-753
  • Objective

    Atypical neuroleptics such as olanzapine are indicated for the treatment of various psychiatric disorders and have been used in the palliative care setting also for several clinical indications. Peripheral and facial edema are a rare side effect of the treatment with olanzapine. We report a case of an advanced cancer patient cared receiving palliative care who developed severe facial edema after initiating a low dose of olanzapine in monotherapy.

    Method

    A patient with advanced cancer who presented with severe facial edema after initiating olanzapine for the treatment of her opioid use disorder.

    Results

    After excluding other differential diagnosis for facial edema, olanzapine was discontinued with complete resolution of the edema.

    Significance of results

    To the best of our knowledge, this is the first case reporting facial edema due to olanzapine treatment in a patient with advanced cancer. Our report will help clinicians recognize the possible role of olanzapine in cases of rapid onset of facial edema, allowing its rapid resolution.